GU Cancers 2019 | Genomic insights and biomarkers for treatment selection in bladder cancer

Yair Lotan

Yair Lotan, MD, of the University of Texas Southwestern Medical Center, Dallas, TX, discusses how identifying clinical biomarkers can significantly help in the selection of treatments for bladder cancer patients. This video was taken at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video